Diabetic Retinopathy Market Surges to USD 13.23 Billion by 2030, Reflecting an 6.7% Growth | MarketDigits
February 09, 2024 04:00 ET
|
PIONEERING MARKETDIGITS CONSULTING AND ADVISORY PRIVATE LIMITED
Richmond, Feb. 09, 2024 (GLOBE NEWSWIRE) -- According to a research report "Diabetic Retinopathy Market”, By Type (Proliferative Diabetic Retinopathy, Diabetic Macular Edema (DME)), Treatment Type...
Rate of Switching from Regeneron’s Eylea to Genentech’s Vabysmo Doubled Over Past Year for Diabetic Macular Edema
November 01, 2023 14:55 ET
|
Spherix Global Insights
Exton, Pennsylvania, Nov. 01, 2023 (GLOBE NEWSWIRE) -- As U.S. ophthalmologists increasingly embrace a wider array of treatment options, the landscape of the diabetic macular edema (DME) market has...
Diabetic Macular Edema Market to Observe Impressive Growth by 2032, Evaluates DelveInsight | Key Companies to Watch Out - Novartis, Roche, Kodiak, Oxurion, Ocuphire, Bausch Health, KalVista, Allegro Opthalmics
October 04, 2023 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Diabetic Macular Edema Market to Observe Impressive Growth by 2032, Evaluates DelveInsight | Key Companies to Watch Out - Novartis, Roche, Kodiak,...
Global Diabetic Retinopathy Market Size To Reach USD 103.2 BN By 2030 | CAGR 16.7%; Spherical Insights & Consulting
September 29, 2022 05:50 ET
|
SPHERICAL INSIGHTS LLP
New York, USA, Sept. 29, 2022 (GLOBE NEWSWIRE) -- The Global Diabetic Retinopathy Market Size Was USD 3.8 Billion In 2020 And Is Projected To Reach USD 103.2 Billion By 2030, Grow A CAGR Of 16.7%....
Diabetic Macular Edema Pipeline Sees Expansion Owing to Key Players, Key Therapies and Research & Programmes
May 12, 2021 20:00 ET
|
DelveInsight Business Research LLP
Los Angeles, USA, May 12, 2021 (GLOBE NEWSWIRE) -- Diabetic Macular Edema Pipeline Sees Expansion Owing to Key Players, Key Therapies and Research & Programmes Diabetic Macular Edema...
AsclepiX Therapeutics partners with Notal Vision on Home OCT remote monitoring in DME and AMD clinical trials
February 23, 2021 08:00 ET
|
Notal Vision
Manassas, VA, Feb. 23, 2021 (GLOBE NEWSWIRE) -- Notal Vision, Inc. announced today that the company will provide AsclepiX Therapeutics with Home OCT monitoring services through its Notal Vision...
Global “Diabetic Macular Edema Market” 2020 Top Countries – Current Landscape And The Way Forwardlong- Lasting VEGF Blockers, Compounds With VEGF- Independent Mechanism And, Topical And Oral Treatment Option – 360 Market Updates
July 19, 2020 09:37 ET
|
Absolute Reports Pvt Ltd
Pune, July 19, 2020 (GLOBE NEWSWIRE) -- Global “Diabetic Macular Edema Market” was ~USD3.7 billion in 2019 with US alone contributing to 51% market share, owing to the higher incidence rates of...
Retinal Disease Therapeutics Market to Reach US$ 21,318.0 Mn by 2026, Advancements in Retinal Disease Diagnosis Devices to Boost the Market, says Fortune Business Insights
July 12, 2019 06:44 ET
|
Fortune Business Insights
Pune, July 12, 2019 (GLOBE NEWSWIRE) -- The global Retinal Disease Therapeutics Market is likely to expand at an impressive rate driven by recent government participation towards prevention and...
Clearside Biomedical, Inc. to Present at the Cowen and Company 37th Annual Health Care Conference
March 01, 2017 17:00 ET
|
Clearside Biomedical, Inc.
ALPHARETTA, Ga., March 01, 2017 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a late-stage biopharmaceutical company developing first-in-class drug therapies to treat back-of-the-eye...
Clearside Biomedical, Inc. Receives Notice of Allowance for Ninth U.S. Patent
March 01, 2017 08:00 ET
|
Clearside Biomedical, Inc.
ALPHARETTA, Ga., March 01, 2017 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a late-stage biopharmaceutical company developing first-in-class drug therapies to treat...